CTNM · Contineum Therapeutics, Inc.
$17.19
+1.17 (+7.30%)
At close · Aug 21
Market Cap
$602.69M
Shares
37.62M
Share-repurchase activity from the company's own XBRL filings — cash spent on equity repurchases (common and preferred combined, as reported) per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Equity Offering (ATM) Programs
| Program Established | Last Amended | Capacity | Remaining | Runs Through | Source |
|---|---|---|---|---|---|
| 2025-05-14 | 2026-03-05 | $100,000,000 | — | — | 10-Q , filed 2026-07-30 |
Repurchase History
| Fiscal Year Ended | Cash Spent | Source |
|---|---|---|
| 2024-12-31 | $0 | 10-K, filed 2025-03-06 |
| 2023-12-31 | $28,000 | 10-K, filed 2025-03-06 |
Key facts
CIK
1855175
CUSIP
21217B100
13F (30d)
98 filings
96 filers
Visit website
Investor relations